Quintin J. Lai - Aug 11, 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Signature
Ryan Metz as Agent for Quintin J. Lai
Stock symbol
WST
Transactions as of
Aug 11, 2023
Transactions value $
-$5,691,372
Form type
4
Date filed
8/15/2023, 02:50 PM
Previous filing
Feb 23, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $786K +8.77K +47.92% $89.64* 27.1K Aug 11, 2023 Direct
transaction WST Common Stock Options Exercise $732K +7.14K +26.37% $102.51 34.2K Aug 11, 2023 Direct
transaction WST Common Stock Options Exercise $580K +3.35K +9.78% $173.22 37.6K Aug 11, 2023 Direct
transaction WST Common Stock Options Exercise $381K +1.39K +3.69% $274.29 39K Aug 11, 2023 Direct
transaction WST Common Stock Options Exercise $167K +453 +1.16% $369.13 39.4K Aug 11, 2023 Direct
transaction WST Common Stock Sale -$4.23M -10.7K -27.22% $394.62 28.7K Aug 11, 2023 Direct F1
transaction WST Common Stock Sale -$3.42M -8.64K -30.11% $395.54 20K Aug 11, 2023 Direct F2
transaction WST Common Stock Sale -$690K -1.74K -8.68% $396.12 18.3K Aug 11, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Option (Right to Buy) Options Exercise $0 -8.77K -100% $0.00* 0 Aug 11, 2023 Common Stock 8.77K $89.64 Direct F4
transaction WST Stock Options (Right to buy) Options Exercise $0 -7.14K -100% $0.00* 0 Aug 11, 2023 Common Stock 7.14K $102.51 Direct F4
transaction WST Stock Options (Right to Buy) Options Exercise $0 -3.35K -75% $0.00 1.12K Aug 11, 2023 Common Stock 3.35K $173.22 Direct F5
transaction WST Stock Options (Right to buy) Options Exercise $0 -1.39K -50% $0.00 1.39K Aug 11, 2023 Common Stock 1.39K $274.29 Direct F6
transaction WST Stock Options (Right to buy) Options Exercise $0 -453 -25% $0.00 1.36K Aug 11, 2023 Common Stock 453 $369.13 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $393.97 to $394.96, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $394.97 to $395.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $395.97 to $396.45, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F4 This option is fully vested.
F5 This award vests in four equal annual installments beginning on February 18, 2021.
F6 This award vests in 4 equal annual installments beginning on 2/23/2022.
F7 This award vests in four equal annual installments beginning on February 22, 2023.